Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7007
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells ; volume:18 ; number:1 ; day:4 ; month:3 ; year:2020 ; pages:1-21 ; date:12.2020
BMC biology ; 18, Heft 1 (4.3.2020), 1-21, 12.2020
- Creator
-
Dunican, Donnchadh S.
Mjoseng, Heidi K.
Duthie, Leanne
Flyamer, Ilya M.
Bickmore, Wendy A.
Meehan, Richard R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12915-020-0752-3
- URN
-
urn:nbn:de:101:1-2020052402221082766138
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dunican, Donnchadh S.
- Mjoseng, Heidi K.
- Duthie, Leanne
- Flyamer, Ilya M.
- Bickmore, Wendy A.
- Meehan, Richard R.
- SpringerLink (Online service)
Other Objects (12)
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Immune pressures drive the promoter hypermethylation of neoantigen genes
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
Modelling the conditional regulatory activity of methylated and bivalent promoters
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
PER3 promoter hypermethylation correlates to the progression of pan-cancer
Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Immune pressures drive the promoter hypermethylation of neoantigen genes
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
Modelling the conditional regulatory activity of methylated and bivalent promoters
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
PER3 promoter hypermethylation correlates to the progression of pan-cancer
Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Immune pressures drive the promoter hypermethylation of neoantigen genes
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
Modelling the conditional regulatory activity of methylated and bivalent promoters
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
PER3 promoter hypermethylation correlates to the progression of pan-cancer
Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer